2020-10-17T10:49:01-05:00 2020-03-31 111986323 MARCUM LLP 1899 L STREET NW SUITE 850 WASHINGTON DC 20036 990 2019-04-01 760514428 MELANOMA RESEARCH FOUNDATION MELA 8006731290 1420 K STREET NW 7TH FLOOR WASHINGTON DC 20005 KYLEIGH LIPIRA CEO 8006731290 2020-10-16 1 FRANK H SMITH P00639053 2022274000 2020-10-12 144.121.95.190 2020-10-16 10:01:33 ED P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 457AE22CA96B0AF98EAE778B37193EFEB5709A29 2019 2021-01-29 14:40:06Z KYLEIGH LIPIRA 1420 K STREET NW 7TH FLOOR WASHINGTON DC 20005 5994872 0 X WWW.MELANOMA.ORG X 1996 TX TO ERADICATE MELANOMA BY ACCELERATING MEDICAL RESEARCH WHILE EDUCATING TO AND ADVOCATING FOR THE MELANOMA COMMUNITY. 13 12 21 475 0 0 5290886 5777261 0 6830 729 14087 60616 -157942 5352231 5640236 1231276 1316954 0 0 1372495 1553124 122700 21542 446310 2080796 2311924 4807267 5203544 544964 436692 1963873 2657969 1445823 1740690 518050 917279 THE MRF IS THE LARGEST INDEPENDENT ORGANIZATION DEVOTED TO MELANOMA. ITS MISSION IS TO ERADICATE MELANOMA BY ACCELERATING MEDICAL RESEARCH WHILE EDUCATING TO AND ADVOCATING FOR THE MELANOMA COMMUNITY. 0 0 1844652 1316954 THE MRF IS COMMITTED TO ADVANCING A BROAD SCIENTIFIC AGENDA ACROSS THE DISCIPLINES OF PREVENTION, DIAGNOSIS AND TREATMENT. ALTHOUGH THE MRF HAS ACHIEVED A NUMBER OF IMPORTANT SCIENTIFIC MILESTONES, MUCH MORE WORK REMAINS TO BE DONE. TO THIS END, THE MRF FUNDS A SPECTRUM OF RESEARCH GRANTS, SCIENTIFIC INITIATIVES, AND PROGRAMS FOR CUTANEOUS MELANOMA AND RARER MELANOMA SUBTYPES (E.G. OCULAR, PEDIATRIC, ACRAL AND MUCOSAL MELANOMA). ITS RESEARCH GRANT PROGRAM IS A COMPETITIVE, PEER-REVIEWED RESEARCH GRANT PROGRAM FOR INVESTIGATOR-INITIATED RESEARCH HAS BEEN IN EXISTENCE SINCE 1998. MRF-SUPPORTED RESEARCH IS OPEN TO MEDICAL STUDENTS THROUGH SENIOR INVESTIGATIVE TEAMS AND ENCOMPASS. 1361239 6830 THE MRF HAS A ROBUST EDUCATION PROGRAM AIMED AT EDUCATING PATIENTS AND PHYSICIANS ABOUT THE PREVENTION, DIAGNOSIS AND TREATMENT OF MELANOMA, AS WELL AS INCREASING OVERALL AWARENESS OF THE DISEASE. IN ADDITION, THE MRF MAINTAINS A LARGE PORTFOLIO OF FREE EDUCATIONAL MATERIALS THAT CAN BE USED AT FUNDRAISERS, DOCTORS' OFFICES, SCHOOLS AND HEALTH FAIRS.PART OF THE MRF'S EDUCATIONAL OFFERINGS ALSO INCLUDE PATIENT-FOCUSED EDUCATIONAL SYMPOSIA THROUGHOUT THE U.S., IMPACTING NEARLY 1,400 PEOPLE TOUCHED BY MELANOMA. THESE SYMPOSIA PROVIDE MELANOMA PATIENTS AND THE PEOPLE WHO SUPPORT THEM THE OPPORTUNITY TO LEARN FROM LEADING MELANOMA EXPERTS ON THE MOST CURRENT PREVENTION, DIAGNOSIS, TREATMENT AND RESEARCH INFORMATION. 1135152 THE MRF'S ADVOCACY PROGRAM IS A PLATFORM FOR THOSE AFFECTED BY MELANOMA TO SHARE THEIR VOICE AND TRANSFORM MELANOMA CARE. PATIENTS, CAREGIVERS, SURVIVORS, HEALTHCARE PROFESSIONALS AND PARTNERS ALL PLAY A CRITICAL ROLE IN THE ADVANCEMENT OF BETTER OUTCOMES FOR THE OVER ONE MILLION AMERICANS LIVING WITH MELANOMA AND THEIR LOVED ONES. 4341043 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 1 0 1 0 0 0 0 0 1 1 0 0 1 1 1 0 0 0 0 0 0 0 1 1 0 0 0 0 1 1 0 0 0 1 19 0 1 21 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 13 12 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 AL AK AZ AR CA CO CT FL GA HI IL KS KY MA MD ME MI MN MS NC ND NH NJ NM NY OH OK OR PA RI UT VA WA WI WV TN SC X KYLEIGH LIPIRA 8006731290 1420 K STREET NW 7TH FLOOR WASHINGTON DC 20005 KYLEIGH LIPIRA CEO 40.00 X 214904 0 8793 BETH ALLGAIER DIRECTOR, CORPORATE RELATIONS 40.00 X 125812 0 18119 SUSAN M DORSEY CPA CONTROLLER 40.00 X 133221 0 5577 STEVE SILVERSTEIN CHAIR 2.00 1.00 X X 0 0 0 CHERYL STRATOS VICE CHAIR 2.00 X X 0 0 0 GEORGE P JAMESON TREASURER 2.00 X X 0 0 0 DOUGLAS BROADMAN SECRETARY - AS OF 12/2019 2.00 X X 0 0 0 JOSEPH FAZIO SECRETARY - UNTIL 12/2019 2.00 X X 0 0 0 STAN ADLER BOARD MEMBER 1.00 X 0 0 0 MANUEL AMEZCUA BOARD MEMBER - UNTIL 02/2020 1.00 X 0 0 0 MICHAEL B ATKINS MD BOARD MEMBER 1.00 1.00 X 0 0 0 REBECCA K DREMAN BOARD MEMBER 1.00 X 0 0 0 JEFFREY HARRIS BOARD MEMBER 1.00 X 0 0 0 ANTHONY T HENDRICKSON BOARD MEMBER 1.00 1.00 X 0 0 0 ALISON MARTIN BOARD MEMBER 1.00 1.00 X 0 0 0 GLENN MERLINO BOARD MEMBER 1.00 X 0 0 0 WILLIAM G REILLY BOARD MEMBER 1.00 X 0 0 0 MARK WEINZIERL BOARD MEMBER 1.00 X 0 0 0 473937 0 32489 3 0 1 0 JONES PUBLIC AFFAIRS 1420 K STREET NW SUITE 1050 WASHINGTON DC 20005 PUBLIC RELATIONS/COMMUNIC. 151896 1 139530 1209695 4428036 210229 5777261 CONTRACT REVENUE 900099 6830 6830 6830 6878 6878 11911 4702 7209 7209 7209 183438 1209695 349934 -166496 -166496 REFUNDS 900099 7641 7641 MERCHANDISE 452000 477 477 OTHER 900099 436 436 8554 5640236 6830 0 -143855 1283954 1283954 33000 33000 233120 76930 156190 1074652 988392 83932 2328 24455 22869 1427 159 120436 94069 14360 12007 100461 76441 12216 11804 1505 1505 77389 54286 23103 126989 126989 21542 21542 440618 390017 19189 31412 21952 16367 3492 2093 331132 285280 9380 36472 246943 184124 39279 23540 166037 118527 31286 16224 250214 214996 14554 20664 398854 304456 3473 90925 69964 49944 13183 6837 18333 13669 2916 1748 RECRUITMENT 82538 62803 10037 9698 BAD DEBT EXPENSES 51408 51408 REGISTRATION FEES 17759 13241 2825 1693 RECOGNITION/AWARDS 10218 7619 1625 974 71 71 5203544 4341043 416191 446310 873558 1373404 15006 49385 638448 339577 3250 0 291593 375613 639914 349682 90153 290232 51865 229758 1963873 2657969 244588 235124 1000000 1212500 201235 293066 1445823 1740690 X -1236576 -449358 1754626 1366637 518050 917279 1963873 2657969 X 436692 -17883 -19580 X 0 1 X 1 0 X 5736841 5651905 5873258 5290886 5777261 28330151 5736841 5651905 5873258 5290886 5777261 28330151 1600176 26729975 145 29 56 123 6878 7231 3989 8152 2552 1789 913 17395 28354777 894416 0.94270 0.93930 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: OTHER - 2015 AMOUNT: $ 3,989. 2016 AMOUNT: $ 8,152. 2017 AMOUNT: $ 2,552. 2018 AMOUNT: $ 1,789. 2019 AMOUNT: $ 913. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 0 0 0 0 1 4428 1 67439 1 55122 126989 0 PART II-B, LINE 1: A LOBBY FIRM IS RETAINED TO ASSIST WITH DEVELOPING, COORDINATING AND IMPLEMENTING AN ALL-ENCOMPASSING ADVOCACY PROGRAM WHICH INCLUDES BUT IS NOT LIMITED TO FEDERAL FUNDING FOR MELANOMA RESEARCH, ISSUES RELATED TO ADOLESCENTS AND YOUNG ADULTS, PEDIATRIC PATIENTS, RARE MELANOMA SUBTYPES, ACCESS TO CARE, PREVENTION AND SURVIVORSHIP. 170608 8386 162222 339154 306382 32772 130152 34914 95238 290232 DEFERRED RENT 272532 DUE TO AFFILIATE 20534 293066 X PART X, LINE 2: THE MRF PERFORMED AN EVALUATION OF UNCERTAINTY IN INCOME TAXES FOR THE YEAR ENDED MARCH 31, 2020, AND DETERMINED THAT THERE WERE NO MATTERS THAT WOULD REQUIRE RECOGNITION IN THE FINANCIAL STATEMENTS OR THAT MAY HAVE ANY EFFECT ON ITS TAX-EXEMPT STATUS. X X X X X X 1 POWERED BY PROFESSIONALS 1375 BROADWAY NEW YORK NY 10018 NEW YORK/ PHILADELPHIA GALA 0 975269 21542 953727 975269 21542 953727 AK AL AR AZ CA CO CT FL GA HI IL KS KY NC ND NH NJ NM NY OH OK OR PA RI SC TN UT VA WA WI WV ME MD MS MA MI MN DC GALA - NEW YORK 902869 791221 111648 11700 110643 500 85766 GALA - DENVER 241588 207493 34095 16257 8196 800 27317 2 248676 210981 37695 17009 35554 500 35692 1393133 1209695 183438 44966 154393 1800 148775 349934 -166496 1 UNIVERSITY OF MIAMI PO BOX 405803 CAMBRIDGE MA 02142 590624458 501(C)(3) 300000 TO SUPPORT MELANOMA CANCER RESEARCH BROAD INSTITUTE 415 MAIN STREET ATLANTA GA 303845803 263428781 501(C)(3) 250000 TO SUPPORT MELANOMA CANCER RESEARCH DUKE UNIVERSITY PO BOX 602651 CHARLOTTE NC 282602651 560532129 501(C)(3) 200000 TO SUPPORT MELANOMA CANCER RESEARCH PENNSYLVANIA STATE UNIVERSITY COLLEGE OF MEDICINE COMPTROLLERS OFFICE PO BOX 850 HERSHEY PA 17033 246000376 501(C)(3) 100000 TO SUPPORT MELANOMA CANCER RESEARCH THOMAS JEFFERSON UNIVERSITY 125 S 9TH STREET SUITE 600 PHILADELPHIA PA 19107 231352651 501(C)(3) 100000 TO SUPPORT MELANOMA CANCER RESEARCH ROCKEFELLER UNIVERSITY VP FOR DEVELOPMENT 1320 YORK AVENUE BOX 164 NEW YORK NY 10065 592451713 501(C)(3) 100000 TO SUPPORT MELANOMA CANCER RESEARCH THE WISTAR INSTITUTE 3601 SPRUCE STREET ATLANTA GA 303845803 236434390 501(C)(3) 100000 TO SUPPORT MELANOMA CANCER RESEARCH ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI ONE GUSTAVE L LEVY PLACE BOX 3500 PHILADELPHIA PA 19104 136171197 501(C)(3) 100000 TO SUPPORT MELANOMA CANCER RESEARCH MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIOUM INC 1411 K STREET SUITE 800 WASHINGTON DC 20005 800671049 501(C)(3) 20534 TO SUPPORT MELANOMA CANCER RESEARCH SOCIETY OF MELANOMA RESEARCH PO BOX 113 CLIFTON NY 12065 810638480 501(C)(3) 10000 TO SUPPORT MELANOMA CANCER RESEARCH 10 0 STUDENT MEDICAL AWARDS 12 33000 PART I, LINE 2: THE MRF'S SCIENTIFIC LEADERSHIP IS COMPRISED OF MULTIDISCIPLINARY EXPERTS IN BASIC AND TRANSLATIONAL RESEARCH, DERMATOLOGY, EPIDEMIOLOGY, GENOMICS, PATHOLOGY, SURGERY AND MEDICAL ONCOLOGY. MEMBERS OF ALL OUR ADVISORY/ STEERING COMMITTEES ARE VOLUNTEERS THAT ASSIST IN PROVIDING THE SCIENTIFIC DIRECTION OF THE MRF. X X X 0 0 0 0 0 0 0 0 0 KYLEIGH LIPIRA CEO 214904 0 0 0 0 0 6750 0 2043 0 223697 0 0 0 STAN ADLER ASSOCIATES STAN ADLER, BOARD MEMBER, IS ALSO THE CHAIR AND FOUNDER OF THE ASSOCIATES 87856 MRF PAID A RETAINER FEE TO THE ASSOCIATES FOR GRAPHIC DESIGN AND MARKETING SERVICES. 0 X 4 210229 FMV 0 0 0 PART I, COLUMN (B): THE MRF REPORTS THE NUMBER OF CONTRIBUTIONS IN PART I, COLUMN (B). FORM 990, PART VI, SECTION B, LINE 11B THE CONTROLLER AND THE CHIEF EXECUTIVE OFFICER REVIEW THE FEDERAL FORM 990 PREPARED BY AN INDEPENDENT ACCOUNTING FIRM. UPON SUBMISSION OF THE FINAL DRAFT, THE FORM 990 IS DISTRIBUTED TO THE BOARD OF DIRECTORS AND THE FINANCE COMMITTEE FOR THEIR REVIEW PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY IS DISTRIBUTED ANNUALLY TO ALL MEMBERS OF THE BOARD OF DIRECTORS, KEY PERSONNEL, AND COMMITTEE MEMBERS. EACH RECIPIENT OF THE POLICY RETURNS A SIGNED AND DATED RESPONSE FORM INDICATING THEY REVIEWED THE POLICY WHILE NOTING IF ANY CONFLICTS EXIST. FOLLOWING THE FULL DISCLOSURE OF A POSSIBLE CONFLICT OF INTEREST DURING THE YEAR, THE BOARD OF DIRECTORS WILL DETERMINE WHETHER A CONFLICT OF INTEREST EXISTS AND THE BOARD MEMBER WITH THE POSSIBLE CONFLICT WILL RECUSE HIMSELF OR HERSELF FROM THE DISCUSSION AND VOTE. FORM 990, PART VI, SECTION B, LINE 15A COMPENSATION FOR THE CHIEF EXECUTIVE OFFICER IS DETERMINED IN THE EXECUTIVE SESSION OF A BOARD OF DIRECTORS MEETING AND IS BASED UPON COMPARABLE SALARY DATA. THE BOARD OF DIRECTORS CONVENES AN AD HOC COMPENSATION COMMITTEE THAT CONTRACTED WITH AN OUTSIDE EXPERT IN SALARY EVALUATION. THIS OUTSIDE GROUP LOOKS AT THE SALARIES OF ALL MRF MANAGEMENT AND COMPARES THOSE SALARIES WITH INDUSTRY STANDARDS, ADJUSTED FOR REGIONAL VARIATIONS. APPROPRIATE ADJUSTMENTS ARE MADE TO ENSURE THAT MRF SALARIES ARE IN KEEPING WITH BEST PRACTICES. THE LAST COMPENSATION REVIEW FOR THE EXECUTIVE DIRECTOR WAS CONDUCTED IN 2016. FORM 990, PART VI, SECTION C, LINE 19 MRF'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART XI, LINE 9: REFUND OF GRANT 31,828. LOSS ON GRANTS AND CONTRIBUTION RECEIVABLE -51,408. MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM INC 1411 K STREET SUITE 800 WASHINGTON DC 20005 800671049 TO ORGANIZE, CONDUCT, AND SUPPORT CLINICAL TRIALS DC 501(C)(3) LINE 12A, I MELANOMA RESEARCH FOUNDATION 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0